These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 39002676)

  • 1. MLL-AF9 regulates transcriptional initiation in mixed lineage leukemic cells.
    Yang Z; Zhang G; Zhao R; Tian T; Zhi J; Wei G; Roeder RG; Jing L; Yu M
    J Biol Chem; 2024 Aug; 300(8):107566. PubMed ID: 39002676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation.
    Chen Y; Ernst P
    Cell Cycle; 2019 Jul; 18(14):1525-1531. PubMed ID: 31161857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program.
    Xu J; Li L; Xiong J; denDekker A; Ye A; Karatas H; Liu L; Wang H; Qin ZS; Wang S; Dou Y
    Cell Discov; 2016; 2():16008. PubMed ID: 27462455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLL::AF9 degradation induces rapid changes in transcriptional elongation and subsequent loss of an active chromatin landscape.
    Olsen SN; Godfrey L; Healy JP; Choi YA; Kai Y; Hatton C; Perner F; Haarer EL; Nabet B; Yuan GC; Armstrong SA
    Mol Cell; 2022 Mar; 82(6):1140-1155.e11. PubMed ID: 35245435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone H3K36me2-Specific Methyltransferase ASH1L Promotes MLL-AF9-Induced Leukemogenesis.
    Aljazi MB; Gao Y; Wu Y; Mias GI; He J
    Front Oncol; 2021; 11():754093. PubMed ID: 34692539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating the Importance of DOT1L Recruitment in MLL-AF9 Leukemia and Hematopoiesis.
    Grigsby SM; Friedman A; Chase J; Waas B; Ropa J; Serio J; Shen C; Muntean AG; Maillard I; Nikolovska-Coleska Z
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562706
    [No Abstract]   [Full Text] [Related]  

  • 7. Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia.
    Chen Y; Jones KL; Anastassiadis K; Kranz A; Stewart AF; Grembecka J; Meyerson M; Ernst P
    Exp Hematol; 2019 Jan; 69():37-42. PubMed ID: 30315824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOT1L complex regulates transcriptional initiation in human erythroleukemic cells.
    Wu A; Zhi J; Tian T; Cihan A; Cevher MA; Liu Z; David Y; Muir TW; Roeder RG; Yu M
    Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34187895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.
    Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J
    J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.
    Monroe SC; Jo SY; Sanders DS; Basrur V; Elenitoba-Johnson KS; Slany RK; Hess JL
    Exp Hematol; 2011 Jan; 39(1):77-86.e1-5. PubMed ID: 20854876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaboration of MLLT1/ENL, Polycomb and ATM for transcription and genome integrity.
    Ui A; Yasui A
    Nucleus; 2016 Apr; 7(2):138-45. PubMed ID: 27310306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis.
    Osaki H; Walf-Vorderwülbecke V; Mangolini M; Zhao L; Horton SJ; Morrone G; Schuringa JJ; de Boer J; Williams O
    Leukemia; 2013 Jul; 27(7):1461-8. PubMed ID: 23403462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human MLL-AF9 Overexpression Induces Aberrant Hematopoietic Expansion in Zebrafish.
    Tan J; Zhao L; Wang G; Li T; Li D; Xu Q; Chen X; Shang Z; Wang J; Zhou J
    Biomed Res Int; 2018; 2018():6705842. PubMed ID: 30003105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.
    Bindels EM; Havermans M; Lugthart S; Erpelinck C; Wocjtowicz E; Krivtsov AV; Rombouts E; Armstrong SA; Taskesen E; Haanstra JR; Beverloo HB; Döhner H; Hudson WA; Kersey JH; Delwel R; Kumar AR
    Blood; 2012 Jun; 119(24):5838-49. PubMed ID: 22553314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of the Shb gene in mixed-lineage leukemia MLL-AF9 cells increases latency in mice despite higher proliferation rates in vitro.
    Jamalpour M; Bergquist E; Welsh M
    Exp Cell Res; 2020 Dec; 397(2):112368. PubMed ID: 33220260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia.
    Zhao Z; Wang L; Volk AG; Birch NW; Stoltz KL; Bartom ET; Marshall SA; Rendleman EJ; Nestler CM; Shilati J; Schiltz GE; Crispino JD; Shilatifard A
    Genes Dev; 2019 Jan; 33(1-2):61-74. PubMed ID: 30573454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape.
    Chiarella E; Aloisio A; Scicchitano S; Todoerti K; Cosentino EG; Lico D; Neri A; Amodio N; Bond HM; Mesuraca M
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia.
    Baker A; Gregory GP; Verbrugge I; Kats L; Hilton JJ; Vidacs E; Lee EM; Lock RB; Zuber J; Shortt J; Johnstone RW
    Cancer Res; 2016 Mar; 76(5):1158-69. PubMed ID: 26627013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting recruitment of disruptor of telomeric silencing 1-like (DOT1L): characterizing the interactions between DOT1L and mixed lineage leukemia (MLL) fusion proteins.
    Shen C; Jo SY; Liao C; Hess JL; Nikolovska-Coleska Z
    J Biol Chem; 2013 Oct; 288(42):30585-30596. PubMed ID: 23996074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.
    Li BE; Ernst P
    Exp Hematol; 2014 Dec; 42(12):995-1012. PubMed ID: 25264566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.